Objective-To examine the long term survival of critically ill patients admitted to an intensive therapy unit and to ascertain the effects of age, severity of illness, and diagnostic category at admission on survival.
prospectively gathered data on all patients admitted to the unit between June 1985 and July 1987 and followed up until 1 January 1989.
Setting-Regional intensive therapy unit. Critically ill adult patients, 16 of whom were excluded because measurements on severity of illness scoring were not available.
Main outcome measures-Age, severity of illness (determined with the acute physiology and chronic health evaluation (APACHE) II score), and diagnostic category on admission; deaths in the unit; and long term survival after discharge. Details of the survivors were sent to the Registrar General for Scotland, who issued copies of death certificates for the patients who had died between discharge and 1 January 1989.
Results-Of 497 patients, 119 (24%) died in the intensive therapy unit and 120 (24%) after discharge, leaving 258 (52%) who were still alive at two years. The median (APACHE II) score was 13 
Patients and methods
All patients admitted to our intensive therapy unit between June 1985 and July 1987 were included in the study. The severity of illness of each patient on admission was assessed with the acute physiology and chronic health evaluation II (APACHE II) scoring system (appendix).4 The patient's age, the diagnosis necessitating admission, and the outcome of intensive treatment were recorded.
Details of patients discharged from the intensive therapy unit, including date of birth and national health number, were reported to the central register for the NHS (office of the Registrar General for Scotland). The registrar issued copies of the death certificates of those patients who had died between the date of their discharge and 1 January 1989. Thus, depending on the date of admission, patients were followed up for between 18 and 42 months after discharge.
Statistical analysis-The effects of age, severity of illness, and diagnostic group at admission on long term outcome were initially examined in a univariate analysis to give Kaplan-Meier survival curves and by log rank tests. This was followed by a multivariate analysis based on the Cox proportional hazards model. A stepwise backwards elimination method was used, and the models were fitted using the biomedical data program statistical package.'
Results
During the two year study period 513 adult patients were admitted to the intensive therapy unit. Sixteen patients were excluded from the study because the required measurements for APACHE II scoring were unavailable. The registrar could not trace 12 of the patients because they had either left Scotland or were living elsewhere in the United Kingdom at the time of their critical illness; these patients were assumed to be still alive.
Of the remaining 497 patients, 119 (24%) died in the unit and 120 (24%) died after discharge, leaving 258 (52%) alive at 1 January 1989. Table I shows the age distribution of the patients, severity of illness, and diagnostic categories. About half of the patients admitted were aged 55 years or more. The median APACHE II score for the whole group was 13 and the Others (including renal failure) 7(12) 12 (21) 39 (67) 58 scores on the 10th and 90th centiles were 5 and 25 respectively. The range of clinical categories was wide.
The number of patients with neurological diagnoses was low, reflecting admission of such patients directly to a regional neurosurgical centre in a different hospital, Figure 1 shows the survival curves from admission for the whole group of 497 patients stratified by age, APACHE II score, and diagnostic category at the time of admission respectively. In all three survival curves the immediate fall represents mortality in the intensive therapy unit and the more gradual decrease reflected death after discharge. Of the 144 patients aged 65 years or more, 68 (47%) were alive at one year but only 55 (38%) were alive at the end of two years. After an initial mortality in the intensive therapy unit of 13% (14/109) there were few deaths after discharge in patients aged [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] . At one year only 41 (34%) of the 122 patients with an APACHE II score of ),e20 on admission were alive compared with 120 (80%) of the 150 patients admitted with a score of <10. Figure Ic shows the mortality for each diagnostic category. Seventy per cent (43/61) of trauma victims survived for one year, but only 41% of patients with a gastrointestinal diagnosis survived for a similar period.
Univariate analysis showed that age (x2=55 1; df=3; p<0001), severity of illness (x2=90.9; df=2; p<0 001), and diagnosis (X2=24-0; df=4; p<0 001) were all predictors of long term survival. Multivariate analysis, however, showed that only age (X2=20 1; df=1; p<0 001) and severity of illness (X2=82 1; df= 1; p<0 001) were independent prognostic factors and that the broad diagnostic category was not (X2 =7-6; df=4; p=0 107). A simplified risk score describing the relation between the combined effects of age and APACHE II score on survival was derived by scaling and rounding the coefficients for Cox's proportional hazards model (table II) , according to the relation simplified risk score = (age) + (APACHE score x 3). (The coefficient for age was approximated to the nearest whole number (actual value 3-31)). Figure 2 shows the survival curves stratified by the simplified risk score, and it illustrates the poor long term survival of patients with a score >75.
Discussion
The demographic details of the patients studied suggest that the variety and severity of conditions Several reports have shown a good correlation between physiological scores on admission to an intensive therapy unit and mortality in the unit.4" Sage et al reported that APACHE II score at admission was a good predictor of death in hospital but not of that after discharge when considered alone. 2 Our results confirmed that the severity of illness at admission has a significant effect on long term outcome.
In certain specific circumstances such as cardiac arrest,'3 head injury,'4 non-traumatic coma,'5 and haematological malignancies'6 there are established guidelines for predicting outcome. Critical illness, however, is usually more complex, affecting simultaneous derangement of several organ systems. Guidelines for admission have been drawn up in the United States,'7 but these are so broad that they offer no advice regarding individual patients. The APACHE system was originally designed to measure the severity of illness on admission, but it is often used to predict outcome for groups of patients. This scoring system does include up to six points allotted for age but our analysis implied that in this context age needs a higher weighting. The combination of age and APACHE II score to estimate the probability of long term survival might be useful when objectively assessing the appropriateness of intensive therapy unit facilities. Though accepting that any risk score will require prospective validation, such a score might help decision making by improving the predictive power of the APACHE II score or of age when used alone. Careful consideration should be given to the appropriateness of starting intensive therapy unit management in patients with high risk scores. This might allow a more reasoned approach when attempting to admit those patients in whom the chances of a reasonable duration and quality of survival merits the time, effort, and expense invested in their treatment. Risk scoring may also help in internal audit, when special attention may be given to the management ofpatients who die despite having a low score.
Diagnosis undoubtedly affects long term mortality. After studying over 5000 patients Knaus et al calculated risk factors for many individual diagnoses to improve prediction of mortality of the APACHE II score.4 In our study the reason for diagnostic category failing to reach significance was probably because of the broad categories used in the statistical analysis. To ensure an equal and reasonable subgroup size for statistical analysis the five categories listed in table I were used; the patients were allocated according to the diagnosis precipitating their admission to the intensive therapy unit and not according to coincidental or subsequent conditions. If this is accepted our study suggests that the effect of diagnosis on long term mortality as opposed to that in the intensive therapy unit might be less than the appreciable influences of APACHE II score and age.
Previous studies examining patients' quality of life after admission to an intensive therapy unit showed that it deteriorates after a critical illness. Searle reported that only 17% of survivors returned to their previously normal life,2 and Ridley and Wallace showed that in patients with a good quality of life before their critical illness, as assessed by Rosser disability categories, this decreased significantly after a critical illness.'8 If there are minimal gains in quality of life long term survival may be of paramount importance to justify starting intensive therapy unit management and measuring its effectiveness.
In conclusion, this study indicates that long term survival after intensive therapy unit treatment is significantly related to the severity of illness on admission and to age: The outcome in patients aged over 65 is poor with only 38% alive at two years. Although further work to refine and validate predictive methods is required before accurate estimates of outcome may be applied to individual patients, risk scoring obtained by combining age and severity of illness scores might be useful when attempting to work out a reasoned admission policy.
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Appendix
The APACHE II score is a simplified form of the original APACHE system, which attempts to measure reliably and objectively the severity ofdisease so that a patient's immediate prognosis may be estimated. The system is based on the principle that the outcome from an acute illness relates to the degree of disturbance in the physiology of the main organ systems, to the patient's age, and to the presence or absence of pre-existing severe chronic health problems.
The main part of this scoring system is an acute physiology score comprising 12 readily available physiological measurements. The value of each measure is given a weight varying from 0 to 12 depending on its deviation from a predetermined normal range and on its relative importance to patient outcome as determined by an expert multidisciplinary panel and by a review of past experience. The resulting acute physiology score varies from 0 to 45; a higher score representing a greater degree of physiological derangement and a higher risk of death. To estimate prognosis this score is combined with additional points for advanced age and preexisting chronic health problems relating to the hepatic, 
